Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | XBP1 | P17861 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13875404 | 0.85 | SMN1; SMN2 (0.45) | ALDH1A1MAPTSMN1; SMN2LMNAGAA | |
| SCHEMBL476901 | 0.85 | MAPT (0.44) | ALDH1A1MAPTSMN1; SMN2LMNAXBP1 | |
| SCHEMBL194429 | 0.85 | SMN1; SMN2 (0.45) | ALDH1A1MAPTSMN1; SMN2LMNAGAA | |
| SCHEMBL30478610 | 0.79 | CES2 (0.50) | ALDH1A1MAPTSMN1; SMN2LMNAGAA | |
| SCHEMBL13982035 | 0.79 | CES2 (0.50) | ALDH1A1MAPTSMN1; SMN2LMNAGAA | |
| SCHEMBL3312136 | 0.79 | CES2 (0.50) | ALDH1A1MAPTSMN1; SMN2LMNAGAA | |
| SCHEMBL665971 | 0.79 | CES2 (0.50) | ALDH1A1MAPTSMN1; SMN2LMNAGAA | |
| SCHEMBL29026525 | 0.78 | GLS (0.38) | ALDH1A1MAPTSMN1; SMN2GAAKDM4E | |
| SCHEMBL29194859 | 0.78 | GLS (0.38) | ALDH1A1MAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL12154914 | 0.76 | CES2 (0.50) | ALDH1A1MAPTLMNAGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100167178-A1 | Oxime sulfonates and the use thereof as latent acids | YAMATO HITOSHI | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100167178-A1 | Oxime sulfonates and the use thereof as latent acids | HAO2, SULT2A1, ARSA | ALDH1A1 62/4885MAPT 4494/4885SMN1; SMN2 3684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.